Belrapzo
Generic name:bendamustine [ BEN-da-MUS-teen ]
Brand names: Belrapzo, Bendeka, Treanda
Drug class:Alkylating agents
What is Belrapzo?
Belrapzo is used to treat chronic lymphocytic leukemia. This medicine is also used to treat indolent B-cell non-Hodgkin lymphoma after other medicines have been tried without successful treatment of this condition.
Belrapzo may also be used for purposes not listed in this medication guide.
Warnings
Tell your caregivers right away if you have any type of skin rash after being treated with Belrapzo.
Before taking this medicine
You should not be treated with Belrapzo if you are allergic to Belrapzo, polyethylene glycol, propylene glycol, or mannitol (Osmitrol).
Tell your doctor if you have ever had:
a weak immune system;
fever or other signs of infection;
herpes zoster (also called shingles)
a metabolic disorder or electrolyte imbalance;
kidney disease; or
if you smoke.
Using Belrapzo may increase your risk of developing certain types of cancer. Ask your doctor about this risk.
Belrapzo can harm an unborn baby or cause birth defects if the mother or the father is using this medicine.
If you are a woman, do not use Belrapzo if you are pregnant. You may need to have a negative pregnancy test before starting this treatment. Use effective birth control to prevent pregnancy while you are using this medicine and for at least 6 months after your last dose.
If you are a man, use effective birth control if your sex partner is able to get pregnant. Keep using birth control for at least 3 months after your last dose.
Tell your doctor right away if a pregnancy occurs while either the mother or the father is using Belrapzo.
This medicine may affect fertility (ability to have children) in men. However, it is important to use birth control to prevent pregnancy because Belrapzo can harm an unborn baby.
Do not breastfeed while using this medicine, and for at least 1 week after your last dose.
How is Belrapzo given?
Belrapzo is given as an infusion ...
